Williams-Sonoma (WSM) closed the most recent trading day at $203.78, moving +1.63% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.49%. Elsewhere, the Dow lost 0.14%, while the tech-heavy Nasdaq lost 0.65%. The seller of cookware and home furnishings's stock has climbed by 18.5% in the past month, exceeding the Retail-Wholesale sector's loss of 1.34% and the S&P 500's gain of 0.96%.The upcoming earnings release of Williams-Sonoma will be of great interest to investors. Th ...

Broadcom Inc. (AVGO) ended the recent trading session at $292.93, demonstrating a -1.61% change from the preceding day's closing price. This change lagged the S&P 500's 0.49% loss on the day. At the same time, the Dow lost 0.14%, and the tech-heavy Nasdaq lost 0.65%. Heading into today, shares of the chipmaker had gained 8.59% over the past month, outpacing the Computer and Technology sector's gain of 3.58% and the S&P 500's gain of 0.96%.The upcoming earnings release of Broadcom Inc. will be of great inter ...

Vestis (VSTS) came out with quarterly earnings of $0.05 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this provider of uniforms and workplace supplies would post earnings of $0.15 per share when it actually produced a loss of $0.05, delivering a surprise of -133.33%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.Ve ...

Company Performance - Oracle's stock increased by 1.24% to $255.67, outperforming the S&P 500, which fell by 0.49% [1] - Over the past month, Oracle shares appreciated by 8.73%, while the Computer and Technology sector gained 3.58% and the S&P 500 gained 0.96% [1] Earnings Forecast - Oracle is expected to report an EPS of $1.47, reflecting a growth of 5.76% year-over-year [2] - Revenue is forecasted to be $15.01 billion, indicating a growth of 12.83% compared to the same quarter last year [2] Annual Estimates - For the annual period, earnings are anticipated to be $6.73 per share, with revenue projected at $66.59 billion, representing increases of 11.61% and 16.02% respectively [3] - Recent analyst estimate revisions for Oracle suggest positive business outlooks, as these changes often reflect short-term business dynamics [3] Valuation Metrics - Oracle has a Forward P/E ratio of 37.52, which is higher than the industry average of 23.97 [5] - The PEG ratio for Oracle is 2.97, compared to the Computer - Software industry's average PEG ratio of 2.25 [6] Industry Ranking - The Computer - Software industry holds a Zacks Industry Rank of 93, placing it in the top 38% of over 250 industries [6] - The Zacks Rank system indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Match Group (MTCH) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.48 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.11%. A quarter ago, it was expected that this media and internet company would post earnings of $0.67 per share when it actually produced earnings of $0.67, delivering no surprise.Over the last four quarters, the c ...

Core Viewpoint - American International Group, Inc. (AIG) is expected to report second-quarter 2025 results on August 6, with earnings estimated at $1.58 per share, reflecting a 36.2% increase from the same quarter last year [1][7]. Earnings Estimates - The earnings estimate for the second quarter has seen five downward revisions in the past 30 days, with no upward revisions [2]. - The Zacks Consensus Estimate for revenues is projected at $6.8 billion, indicating a 2.7% growth compared to the previous year [2]. Earnings Surprise History - AIG has surpassed earnings estimates in three of the last four quarters, with an average surprise of 1.73% [3]. Earnings Prediction Model - AIG is predicted to beat earnings expectations due to a positive Earnings ESP of +1.40%, with the most accurate estimate at $1.61 per share [4][5]. Revenue and Income Projections - General Insurance revenues are anticipated to rise by 4% to $6 billion, driven by strong performance in commercial and personal lines [7]. - Net investment income is expected to decline by 4.4% to $946 million due to weaker returns from alternative assets [7][11]. General Insurance Performance - The General Insurance segment is projected to benefit from strong performances in North America Commercial, International Commercial, and Global Personal segments [9]. - The consensus for General Insurance's adjusted pretax income stands at $1.3 billion, reflecting a 13.9% year-over-year growth [11]. Cost and Margin Considerations - Despite cost-cutting measures, AIG's margins are likely to be impacted by a high expense base due to increased losses and loss adjustment expenses [12].

Core Insights - GigaCloud Technology Inc. (GCT) is expected to report a year-over-year decline in total revenues for Q2 2025, with estimates at $290.2 million, reflecting a 6.7% decrease [1][10] - Product revenues are projected to decline significantly by 20.4% to $179 million, attributed to normalization in order volumes and potential macroeconomic softness in cross-border e-commerce [1][2][10] - Service revenues are anticipated to grow by 30.6% to $111 million, which may partially offset the decline in product revenues [2][10] - Earnings per share are expected to decrease by 29.2% to 46 cents, linked to rising operational costs and lower revenue leverage [3] Revenue Breakdown - Total revenues for Q2 2025 are estimated at $290.2 million, down 6.7% year-over-year [1][10] - Product revenues are expected to be $179 million, indicating a 20.4% decline [1][10] - Service revenues are projected to reach $111 million, reflecting a growth of 30.6% [2][10] Earnings Outlook - The Zacks Consensus Estimate for earnings is set at 46 cents per share, a decrease of 29.2% from the previous year [3] - GCT currently has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell), indicating a low probability of an earnings beat [4][5]

Core Insights - Wheaton Precious Metals (WPM) is set to report its second-quarter 2025 results on August 7, with sales estimated at $467.7 million, reflecting a 56.4% year-over-year growth [1][5] - The consensus estimate for WPM's earnings is 58 cents per share, indicating a 75.8% increase compared to the previous year [1][5] - Earnings estimates have risen by 16% over the past 60 days [1] Financial Performance - WPM's earnings have exceeded consensus estimates in two of the last four quarters, with an average surprise of 5.9% [3] - The projected total attributable production for WPM in Q2 2025 is 148,461 gold equivalent ounces (GEOs), marking a 2.6% year-over-year increase [8] - Gold production is expected to be 86,697 ounces, a 3.8% increase year-over-year, with gold sales projected at $281 million, indicating a 54% year-over-year rise [10][11] Production Insights - The company anticipates an attributable production of 600,000-670,000 GEOs for 2025, representing a 10% year-over-year increase [7] - Silver production is projected at 5.11 million ounces, a 1.3% increase year-over-year, with silver sales expected to reach $151 million, a 35.8% year-over-year rise [12][13] - Attributable production of palladium is expected to decline by 45.4% year-over-year, while cobalt production is projected to increase by 43.8% [14] Market Performance - WPM's stock has increased by 75.9% over the past year, significantly outperforming the industry average growth of 10.4% [16]

Core Insights - Becton Dickinson and Company (BDX) is set to report its third-quarter fiscal 2025 results on August 7, with expectations of revenue growth despite a slight decline in earnings per share (EPS) [2][11][14]. BD Medical - The BD Medical segment is anticipated to see a revenue increase of 17.7% year over year, driven by the launch of the HemoSphere Alta Advanced Monitoring Platform and the BD neXus infusion pump [4][6][11]. - Management has confirmed progress in the Connected Care strategy, including 510(k) clearance for BD Alaris enhancements [5]. BD Life Sciences - The BD Life Sciences segment is projected to experience a revenue decline of 4.2% year over year, attributed to unfavorable market dynamics and slower recovery in blood culture testing [8][9]. - The global launch of the BD FACSDiscover A8 Cell Analyzer is expected to enhance product adoption and drive revenues [7]. BD Interventional - The BD Interventional segment's revenues are expected to rise by 2.9% year over year, supported by sustained demand and the launch of the Phasix ST hernia patch [11][13]. - The Phasix ST Umbilical Hernia Patch is noted as the first fully absorbable hernia patch specifically for umbilical hernias [12]. Financial Estimates - The overall revenue estimate for Q3 fiscal 2025 is $5.48 billion, reflecting a 9.9% increase from the previous year, while EPS is expected to decrease by 2.3% to $3.42 [11][14]. - The company has a forward 12-month price-to-earnings (P/E) ratio of 12.3X, which is lower than the industry average of 16.2X, indicating potential for growth [20][21]. Strategic Developments - BD plans to invest over $35 million to expand prefilled flush syringe manufacturing, which is expected to enhance production capacity [22][25]. - The company has submitted an application for a new at-home HPV test and received FDA clearance for the BD Veritor System for COVID-19, indicating ongoing innovation [26]. - A definitive agreement with Waters Corporation aims to combine their Biosciences & Diagnostic Solutions business, enhancing BD's strategic focus [27]. Market Performance - BD's shares have increased by 8.3% over the past three months, outperforming its peers in the Medical - Dental Supplies sector [17][19]. - The company is trading at a discount compared to its peers, suggesting potential for future growth if it aligns more closely with market performance [21][31].

Core Viewpoint - Celestica (CLS) shows a significant improvement in earnings outlook, making it an attractive investment option as analysts continue to raise earnings estimates for the company [1][2]. Earnings Estimate Revisions - The rising trend in earnings estimate revisions reflects growing analyst optimism regarding Celestica's earnings prospects, which is expected to positively impact its stock price [2]. - For the current quarter, Celestica is projected to earn $1.45 per share, representing a 39.4% increase from the previous year, with a 14.96% rise in the Zacks Consensus Estimate over the last 30 days [7]. - For the full year, the earnings estimate is $5.55 per share, indicating a 43.0% increase from the prior year, with three estimates moving up and no negative revisions [8]. Zacks Rank and Performance - Celestica has achieved a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, which historically correlate with strong stock performance [9]. - Stocks with Zacks Rank 1 and 2 significantly outperform the S&P 500, indicating a strong potential for Celestica's stock [9]. Recent Stock Performance - Celestica shares have increased by 30.8% over the past four weeks, suggesting investor confidence in the company's earnings growth prospects [10].